The production of neutralizing IgA at early stages of the infection could effectively eliminate the virus in the respiratory mucosa, whereas the persistence of both IgA and IgG in the serum over the time can trigger the immune response in mild cases [13]. The gene discussed is CD79A; the disease is infection.